hyperphosphatemia

You have accessRestricted Access
Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis
David E. St-Jules, Mary R. Rozga, Deepa Handu and Juan Jesus Carrero

CJASN January 2021, 16 (1) 107-120; DOI: https://doi.org/10.2215/CJN.09360620

Add to Selected Citations
You have accessRestricted Access
Dietary Therapy for Managing Hyperphosphatemia
Yoko Narasaki and Connie M. Rhee

CJASN January 2021, 16 (1) 9-11; DOI: https://doi.org/10.2215/CJN.18171120

Add to Selected Citations
Open Access
Fibroblast Growth Factor 23 and the Last Mile
Orlando M. Gutiérrez

CJASN September 2020, 15 (9) 1355-1357; DOI: https://doi.org/10.2215/CJN.13631119

Add to Selected Citations
You have accessRestricted Access
Dietary Phosphorus and FGF23
Kathleen M. Hill Gallant

CJASN October 2019, 14 (10) 1424-1426; DOI: https://doi.org/10.2215/CJN.09640819

Add to Selected Citations
You have accessRestricted Access
Parathyroidectomy in the Management of Secondary Hyperparathyroidism
Wei Ling Lau, Yoshitsugu Obi and Kamyar Kalantar-Zadeh

CJASN June 2018, 13 (6) 952-961; DOI: https://doi.org/10.2215/CJN.10390917

Add to Selected Citations
You have accessRestricted Access
The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD
Rakesh Malhotra, Ronit Katz, Andrew Hoofnagle, Andrew Bostom, Dena E. Rifkin, Ruth Mcbride, Jeffrey Probstfield, Geoffrey Block and Joachim H. Ix

CJASN January 2018, 13 (1) 36-44; DOI: https://doi.org/10.2215/CJN.05440517

Add to Selected Citations
You have accessRestricted Access
Lowering Expectations with Niacin Treatment for CKD-MBD
Tilman B. Drüeke and Ziad A. Massy

CJASN January 2018, 13 (1) 6-8; DOI: https://doi.org/10.2215/CJN.12021017

Add to Selected Citations
You have accessRestricted Access
Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD
Rupal Mehta and Tamara Isakova

CJASN December 2017, 12 (12) 1911-1913; DOI: https://doi.org/10.2215/CJN.11011017

Add to Selected Citations
You have accessRestricted Access
Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders
Hirotaka Komaba, Mia Wang, Masatomo Taniguchi, Suguru Yamamoto, Takanobu Nomura, Douglas E. Schaubel, Abigail R. Smith, Jarcy Zee, Angelo Karaboyas, Brian Bieber, Masafumi Fukagawa and Francesca Tentori

CJASN September 2017, 12 (9) 1489-1497; DOI: https://doi.org/10.2215/CJN.13091216

Add to Selected Citations
You have accessRestricted Access
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial
Ron Wald, Christian G. Rabbat, Louis Girard, Amit X. Garg, Karthik Tennankore, Jessica Tyrwhitt, Andrew Smyth, Andrea Rathe-Skafel, Peggy Gao, Andrea Mazzetti, Jackie Bosch, Andrew T. Yan, Patrick Parfrey, Braden J. Manns and Michael Walsh

CJASN June 2017, 12 (6) 965-973; DOI: https://doi.org/10.2215/CJN.10941016

Add to Selected Citations

Main menu

User menu

Search

hyperphosphatemia

Pages

Articles

Information for Authors

About

Journal Information

More Information